Oncotarget 6(28):25917 [DOI] [PMC free article] [PubMed] [Google Scholar] Wang Y, Patel A, Douglas RS (2019) Thyroid eye disease: how a novel therapy may change the treatment paradigm
[32] Australia A 2003 Phase IIb clinical human trial demonstrated in a group of seventy-nine volunteers that those who were administered [Nle 4 , D-Phe 7 ]-MSH daily for a period of three months had highly significant increases in skin-melanin while those who were not, did not
However, creatine increases intramuscular water retention and places modest metabolic demand on the kidneys
What the infusion includes, how a typical session
But with the GLP-1s, which we're using all the time now, it's not as big of a deal, but I thought I'd mention that